FIGURE 11.
The m6A-RLPS is related with the tumor microenvironment (TME) immune reaction. (A) Differential drug sensitivity. (B) Distribution of TME scores in the risk groups. (C) Differential expression of five immune checkpoints in the risk groups. (D) Nearly all selected immune checkpoints correlated positively with the risk score.